Philips Advanced Visualization Workspace – IntelliSpace Portal 12 - wins EuroMinnie award for Best New Radiology Software

For the second consecutive year, Philips has won a EuroMinnie award in the category of Best New Radiology Software, in recognition of its next generation Advanced Visualization Workspace – IntelliSpace Portal 12.

Recently launched at the 2020 virtual Radiological Society of North America Scientific Assembly and Annual Meeting in December, the next generation of IntelliSpace Portal features a robust set of new AI-assisted quantitative assessment and automated features to support the diagnostic workflow, including follow-up and communication across cardiology, pulmonology, oncology and neurology. Its AI-assisted pulmonary capabilities include the automated COVID-19 assessment COVID-19.

“We are honored to receive this latest accolade for our Advanced Visualization Workspace. The new generation of IntelliSpace Portal adds numerous AI-enabled features that automatically generate quantitative measurements, simplify workflows, and make radiology data available anywhere it’s clinically relevant in an organization,” said Calum Cunningham, General Manager of Enterprise Diagnostic Informatics at Philips.

Read more from Calum in his interview with AuntMinnieEurope.com.

New clinical software packages [1] in cardiology, pulmonology, oncology and neurology are now available in IntelliSpace Portal 12, several of which expanding the ecosystem of radiology solutions, though integrative in collaboration with Pie Medical Imaging BV or Riverain Technologies. Some of the innovation in this latest version includes:

Cardiology

MR Cardiac Analysis – Pre-processing images to deliver AI-based right ventricle and left ventricle segmentation to ensure accurate volumetric and functional measurements, enabling completion of a full cardiac MRI functional analysis in less than 5 minutes [2].
 
MR Caas™ 4D Flow Analysis – To reduce analysis time and improve reliability of valvular flow quantification [3], Caas [4] MR 4D Flow visualizes and quantifies blood flow patterns in a patient’s heart and main arteries.

Pulmonology

CT Pulmo Auto Results [5] – Featuring AI algorithms trained on COVID-19 CT scans, CT Pulmo Auto Results software performs automatic lung segmentation and lesion segmentation, together with classification of ground glass opacities/consolidation. Its automatically generated reports include volume summaries and lesion distribution data to help in the quantitative assessment of pulmonary infiltrates, enhancing diagnostic confidence without increasing reading time.

Oncology

CT ClearRead™ CAD Lung Nodule Analysis [6] – featuring AI-based detection and characterization for various nodule types including solid, part-solid and ground-glass lung nodules, enabling to perform nodule searches 26% faster and detect 29% of previously missed nodules [7].

Neurology

CT Brain Perfusion Analysis – IntelliSpace Portal 12 now supports automatic brain perfusion measurements instantly available on PACS with the option of automatically emailing perfusion results to a stroke patient’s clinicians within two minutes to reduce door-to-needle time.

Philips advanced visualization software (IntelliSpace Portal 12) will be featured at the upcoming European Congress of Radiology virtual event March 3-8.  For more information on Philips’ portfolio of diagnostic and interventional solutions and AI-enabled applications to enhance radiology workflows at ECR 2021, visit www.philips.com/ecr and follow @PhilipsLiveFrom for updates throughout the event.

[1] Some IntelliSpace Portal functionalities may not be available in all territories.
[2] Average RV/LV analysis time measured on validation study 4.2 min +/- 0.4
[3] V.P. Kamphuis et al., Automated Cardiac Valve Tracking for Flow Quantification with Four-dimensional Flow MRI, Radiology, 2019 Jan;290(1):70-78
[4] Caas is a trademark of Pie Medical Imaging BV.
[5] The functionality may not be available in all territories. In the United States of America, the CT Pulmo Auto Results can only be used during the National Emergency Concerning the Novel Coronavirus Disease (COVID-19). The CT Pulmo Auto Results functionality is exempt from premarket notification according to the FDA Guidance document for Imaging Systems During the Coronavirus Disease 2019 (COVID-19), and was therefore not cleared by the FDA. It is offered via a trial license only for the duration of the national emergency, until further notice.
[6] ClearRead CT is a trademark of Riverain Technologies.
[7] ShihChung et al. AJR 2018; 210:480-488